Literature DB >> 18050369

Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases.

Kenichiro Tamaki1, Yoshinori Kogata, Daisuke Sugiyama, Takashi Nakazawa, Saori Hatachi, Gohichi Kageyama, Kunihiro Nishimura, Akio Morinobu, Shunichi Kumagai.   

Abstract

OBJECTIVE: To examine whether serum procalcitonin (PCT) concentrations are useful for distinguishing bacterial infections from disease flares in patients with systemic autoimmune diseases.
METHODS: Patients with systemic autoimmune diseases who were admitted to our hospitals due to either a suspected deterioration of their primary diseases or an infectious disease were enrolled. Serum PCT levels were measured in 99 serum samples of 98 patients who had elevated serum C-reactive protein (CRP) levels; 29 samples were obtained from patients with bacterial infections, and 70 samples were obtained from patients with disease deterioration without a detectable infection. The diagnostic accuracy, sensitivity, and specificity for identifying a bacterial infection were estimated using the receiver-operating characteristic curve. Multiple logistic regression analysis was also done with PCT level, age, sex, steroid dose, and use of immunosuppressive agents.
RESULTS: Serum PCT levels were higher in the bacterial infection group than in the disease flare group (mean +/- SD, 4.539 +/- 9.677 vs 0.116 +/- 0.127; p < 0.0001). The diagnostic accuracy of PCT for bacterial infection was 0.797, sensitivity 53.3%, and specificity 97.1%. On multivariate analysis, the odds ratio of a PCT > or = 0.5 ng/ml was significant (OR 59.085, 95% CI 7.705 453.088, p < 0.0001) for identifying bacterial infection.
CONCLUSION: Elevated serum PCT levels have a good specificity for diagnosing bacterial infection in patients with systemic autoimmune diseases regardless of their dosage of oral corticosteroids and immunosuppressive agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18050369

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

Review 1.  Validation of new biomarkers in systemic autoimmune diseases.

Authors:  Maria G Tektonidou; Michael M Ward
Journal:  Nat Rev Rheumatol       Date:  2011-11-01       Impact factor: 20.543

2.  Late-onset deep surgical-site infection after posterior lumbar interbody fusion in a patient treated with tocilizumab; unusual changes in inflammatory markers.

Authors:  Takahiro Makino; Takashi Kaito; Hideki Tsuboi; Hiroyasu Fujiwara; Kazuo Yonenobu
Journal:  Eur Spine J       Date:  2014-04-24       Impact factor: 3.134

3.  Relationship between procalcitonin serum levels and functional outcome in stroke patients.

Authors:  Wen-Jing Deng; Rui-Le Shen; Meng Li; Jun-Fang Teng
Journal:  Cell Mol Neurobiol       Date:  2014-11-05       Impact factor: 5.046

4.  Procalcitonin Is a Stronger Predictor of Long-Term Functional Outcome and Mortality than High-Sensitivity C-Reactive Protein in Patients with Ischemic Stroke.

Authors:  Chao Wang; Li Gao; Zhi-Guo Zhang; Yu-Qian Li; Yan-Long Yang; Tao Chang; Long-Long Zheng; Xing-Ye Zhang; Ming-Hao Man; Li-Hong Li
Journal:  Mol Neurobiol       Date:  2015-02-04       Impact factor: 5.590

Review 5.  Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia.

Authors:  Mirjam Christ-Crain; Steven M Opal
Journal:  Crit Care       Date:  2010-02-08       Impact factor: 9.097

6.  Delayed spinal infection after laminectomy in a patient with rheumatoid arthritis interruptedly exposed to anti-tumor necrosis factor alpha agents.

Authors:  Shunsuke Mori; Yusuke Tomita; Tomohiro Horikawa; Isamu Cho; Mineharu Sugimoto
Journal:  Clin Rheumatol       Date:  2008-03-11       Impact factor: 2.980

7.  Serum procalcitonin for differentiating bacterial infection from disease flares in patients with autoimmune diseases.

Authors:  Kowoon Joo; Won Park; Mie-Jin Lim; Seong-Ryul Kwon; Jiyeol Yoon
Journal:  J Korean Med Sci       Date:  2011-09-01       Impact factor: 2.153

8.  Analysis of procalcitonin and CRP concentrations in serum of patients with chronic spontaneous urticaria.

Authors:  A Kasperska-Zajac; A Grzanka; E Machura; B Mazur; M Misiolek; E Czecior; J Kasperski; J Jochem
Journal:  Inflamm Res       Date:  2012-12-04       Impact factor: 4.575

9.  The utility of initial procalcitonin and procalcitonin clearance for prediction of bacterial infection and outcome in critically ill patients with autoimmune diseases: a prospective observational study.

Authors:  Yan Shi; Jin-min Peng; Xiao-yun Hu; Yao Wang
Journal:  BMC Anesthesiol       Date:  2015-10-07       Impact factor: 2.217

10.  Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.

Authors:  Chou-Han Lin; Song-Chou Hsieh; Li-Ta Keng; Ho-Sheng Lee; Hou-Tai Chang; Wei-Yu Liao; Chao-Chi Ho; Chong-Jen Yu
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.